CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Cash flows provided by (used in) operating activities
Net income (loss)	$ 49,981	$ (29,990)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Provision for credit losses	3,058	45,593
Amortization of intangible assets	4,291	3,083
Amortization of mortgage servicing rights	203	168
Depreciation and amortization of premises and equipment	3,578	2,649
Net amortization (accretion) on portfolio loans	(5,626)	(1,164)
Net amortization (accretion) of premium (discount) on investment securities	(450)	1,437
Net amortization (accretion) of premium (discount) on time deposits	8	(659)
Net amortization (accretion) of premium (discount) on FHLB advances and other borrowings	462	433
Impairment of fixed assets held for sale	11	188
Impairment of mortgage servicing rights	(147)	(2)
Unrealized (gains) losses recognized on equity securities, net	963	231
(Gain) loss on sales of debt securities, net	(23)	15,537
(Gain) loss on sales of loans, net	(315)	(197)
(Gain) loss on sales of OREO and other repossessed assets	(15)	(16)
(Gain) loss on sales of premises and equipment	(85)	25
(Gain) loss on life insurance proceeds	0	(211)
Increase in cash surrender value of bank owned life insurance	(1,616)	(1,235)
Provision for deferred income taxes expense (benefit)	(4,728)	1,761
Stock-based compensation expense	4,136	3,394
Mortgage loans originated for sale	(18,887)	(13,169)
Proceeds from sales of mortgage loans	19,732	9,802
(Increase) decrease in other assets	8,272	(7,135)
Decrease in other liabilities	(11,268)	(22,141)
Net cash provided by operating activities	51,535	8,382
Cash flows provided by (used in) investing activities
Purchases of interest-bearing time deposits in other banks	(245)	(100)
Proceeds from maturities of interest-bearing time deposits in other banks	345	710
Purchases of equity securities	0	(742)
Proceeds from sales of equity securities	1	5,650
Purchases of debt securities available for sale	(140,488)	(336,428)
Proceeds from sales of debt securities available for sale	0	528,940
Proceeds from paydowns and maturities of debt securities available for sale	75,213	92,454
Proceeds from paydowns and maturities of debt securities held to maturity	21,401	11,754
Purchases of restricted bank stock	(8,757)	(10)
Proceeds from the redemption of restricted bank stock	4,041	3
Net (increase) decrease in loans	104,603	(93,249)
Net cash received in (paid for) acquisitions (see Note 2)	0	385,804
Cash paid for premiums on bank-owned life insurance	(42)	(46)
Proceeds from life insurance	0	3,306
Purchases of premises and equipment	(2,458)	(1,797)
Proceeds from disposition of premises and equipment	296	0
Net proceeds from OREO and other repossessed assets	1,303	14,576
Net cash provided by investing activities	55,213	610,825
Cash flows provided by (used in) financing activities
Net decrease in deposits	(169,906)	(94,060)
Net decrease in federal funds purchased and securities sold under agreements to repurchase	(10,565)	(18,270)
Proceeds from short-term borrowings	5,276,801	0
Repayment of short-term borrowings	(5,106,801)	0
Proceeds from other borrowings, net of debt issuance costs	11,000	16,667
Repayment of other borrowings	(45)	(30)
Cash dividends paid	(27,200)	(14,224)
Purchase of treasury stock	(66,149)	(4,836)
Cash paid for withholding taxes on stock-based payments	(6,486)	(910)
Issuance of treasury stock for the ESPP	838	619
Common stock issuance costs	0	(920)
Net cash used in financing activities	(98,513)	(115,964)
Net increase in cash and cash equivalents	8,235	503,243
Cash and cash equivalents, beginning of period	280,227	682,410
Cash and cash equivalents, ending of period	288,462	1,185,653
Cash payments for:
Interest	70,701	42,514
Non-cash investing and financing activities:
OREO and other repossessed assets acquired in settlement of loans	0	14,844
Transfer of loans held for sale to portfolio loans	$ 10	$ 0